These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26957191)

  • 1. Doxorubicin conjugated functionalizable carbon dots for nucleus targeted delivery and enhanced therapeutic efficacy.
    Yang L; Wang Z; Wang J; Jiang W; Jiang X; Bai Z; He Y; Jiang J; Wang D; Yang L
    Nanoscale; 2016 Mar; 8(12):6801-9. PubMed ID: 26957191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-pH Sensitive Charge-Reversal Drug Delivery System for Highly Precise and Penetrative Chemotherapy.
    Chen W; Li J; Xing Y; Wang X; Zhang H; Xia M; Wang D
    Pharm Res; 2020 Jul; 37(7):134. PubMed ID: 32642819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turn-on theranostic fluorescent nanoprobe by electrostatic self-assembly of carbon dots with doxorubicin for targeted cancer cell imaging, in vivo hyaluronidase analysis, and targeted drug delivery.
    Gao N; Yang W; Nie H; Gong Y; Jing J; Gao L; Zhang X
    Biosens Bioelectron; 2017 Oct; 96():300-307. PubMed ID: 28511113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-Loaded Carbon Dots Lipid-Coated Calcium Phosphate Nanoparticles for Visual Targeted Delivery and Therapy of Tumor.
    Zhang J; Zhang H; Jiang J; Cui N; Xue X; Wang T; Wang X; He Y; Wang D
    Int J Nanomedicine; 2020; 15():433-444. PubMed ID: 32021189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-loaded environmentally friendly carbon dots as a novel drug delivery system for nucleus targeted cancer therapy.
    Yuan Y; Guo B; Hao L; Liu N; Lin Y; Guo W; Li X; Gu B
    Colloids Surf B Biointerfaces; 2017 Nov; 159():349-359. PubMed ID: 28806666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of reduction-responsive micelles based on disulfide-linked chondroitin sulfate A-tocopherol succinate for controlled antitumour drug release.
    Cai S; Xie X; Yuan Q; Ding J; Meng L; Li J; He M; Li W; Yu J
    J Pharm Pharmacol; 2021 Sep; 73(10):1405-1417. PubMed ID: 34254648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cucumber mosaic virus as drug delivery vehicle for doxorubicin.
    Zeng Q; Wen H; Wen Q; Chen X; Wang Y; Xuan W; Liang J; Wan S
    Biomaterials; 2013 Jun; 34(19):4632-42. PubMed ID: 23528229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrazone-bearing PMMA-functionalized magnetic nanocubes as pH-responsive drug carriers for remotely targeted cancer therapy in vitro and in vivo.
    Ding X; Liu Y; Li J; Luo Z; Hu Y; Zhang B; Liu J; Zhou J; Cai K
    ACS Appl Mater Interfaces; 2014 May; 6(10):7395-407. PubMed ID: 24749476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and evaluation of PAMAM-DOX conjugates with superior tumor recognition and intracellular acid-triggered drug release properties.
    Cheng L; Hu Q; Cheng L; Hu W; Xu M; Zhu Y; Zhang L; Chen D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():37-45. PubMed ID: 26360738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High loading and sustained-release system of doxorubicin-carbon dots as nanocarriers for cancer therapeutics.
    Prasad A; Sekar RP; Razana C A M; Sudhamani SD; Das A; Athipettah J; Ngashangva L
    Biomed Mater; 2024 Oct; 19(6):. PubMed ID: 39317335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells.
    Han M; Vakili MR; Soleymani Abyaneh H; Molavi O; Lai R; Lavasanifar A
    Mol Pharm; 2014 Aug; 11(8):2640-9. PubMed ID: 24811541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors.
    van Lummel M; van Blitterswijk WJ; Vink SR; Veldman RJ; van der Valk MA; Schipper D; Dicheva BM; Eggermont AM; ten Hagen TL; Verheij M; Koning GA
    FASEB J; 2011 Jan; 25(1):280-9. PubMed ID: 20876209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
    Misra R; Sahoo SK
    Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
    Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of polydopamine as a new and biocompatible coating of magnetic nanoparticles for delivery of doxorubicin in mouse breast adenocarcinoma.
    Zavareh S; Mahdi M; Erfanian S; Hashemi-Moghaddam H
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):1073-1084. PubMed ID: 27752764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple preparation of maltose-functionalized dendrimer/graphene quantum dots as a pH-sensitive biocompatible carrier for targeted delivery of doxorubicin.
    Karimi S; Namazi H
    Int J Biol Macromol; 2020 Aug; 156():648-659. PubMed ID: 32289413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic.
    Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
    J Control Release; 2005 Oct; 107(2):262-75. PubMed ID: 16125816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.